Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Precautions and Warnings With Aldesleukin

Specific Aldesleukin Precautions and Warnings

Some warnings and precautions to be aware of prior to receiving this medication include the following:
 
  • Aldesleukin can cause damage to the heart, lungs, kidneys, liver, and central nervous system. Because of the risks associated with its use, this medication should only be given to people who have normal heart, lung, liver, and central nervous system function. Your healthcare provider will perform certain tests to make sure you are a candidate for aldesleukin treatment.
 
  • This medication should only be used in a hospital with an intensive care unit, and only under the supervision of a healthcare provider with experience using medications to treat cancer.
 
  • Aldesleukin has been associated with a life-threatening condition known as capillary leak syndrome. This condition occurs when fluid from blood vessels leaks out into nearby body cavities and muscles, causing low blood pressure and potential damage to vital organs. You will be closely monitored for capillary leak syndrome during treatment.
 
  • You may have an increased risk for infection during aldesleukin treatment, including potentially life-threatening infections of the blood and the lining of the heart. If you have a bacterial infection before starting aldesleukin, the infection will need to be treated prior to receiving your first dose. Your healthcare team will monitor you for infections during treatment. You may be given antibiotics to help prevent an infection from occurring.
 
  • This medication can cause significant central nervous system effects, such as:
 
    • Severe drowsiness and fatigue
    • Confusion
    • Depression
    • Difficulty walking or talking
    • Agitation
    • Seizures
    • Coma.
 
Your healthcare provider will stop treatment with aldesleukin if you develop any potentially serious central nervous system side effects. Let your healthcare provider know if you feel extremely drowsy during treatment.
 
  • Aldesleukin may cause or worsen autoimmune or inflammatory conditions. Make sure your healthcare provider knows if you have an autoimmune disease or inflammatory condition before beginning treatment.
 
 
  • You will be closely monitored every day you receive this medication to check for any potentially serious side effects. Monitoring will include vital signs, such as heart rate, blood pressure, and temperature; lab tests to check your blood cell counts; and liver, heart, and kidney function tests. If any of the tests are abnormal, your healthcare provider may recommend you skip a dose or stop treatment.
 
 
  • Aldesleukin is a pregnancy Category C medication, which means it may not be safe for use during pregnancy (see Proleukin and Pregnancy).
 
  • It is unknown whether aldesleukin passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to receiving the drug (see Proleukin and Breastfeeding).
 
The Zen of Cancer Caregiving - Recharge Your Batteries!

Aldesleukin Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.